These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1341062)

  • 21. New ways to boost factor VIII in hemophilia: DDAVP for mild hemophilia A, von Willebrand's.
    Marwick C
    JAMA; 1983 Jun; 249(24):3278-9. PubMed ID: 6406692
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparative study using immunological and biological assay of the haemostatic responses to DDAVP infusion venous occlusion and exercise in normal men.
    Prowse CV; Farrugia A; Boulton FE; Tucker J; Ludlam CA; McLaren M; Belch JJ; Prentice CR; Dawes J; MacGregor IR
    Thromb Haemost; 1984 Feb; 51(1):110-4. PubMed ID: 6426076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1-Deamino-8-D-arginine vasopressin lowers protein C activity in uremics.
    Aunsholt NA; Schmidt EB; Stoffersen E
    Nephron; 1989; 53(1):6-8. PubMed ID: 2506477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal DDAVP: biological and clinical evaluation in mild factor VIII deficiency.
    Chistolini A; Dragoni F; Ferrari A; La Verde G; Arcieri R; Ege Mohamud A; Mazzucconi MG
    Haemostasis; 1991; 21(5):273-7. PubMed ID: 1806455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP.
    Brommer EJ; Derkx FH; Barrett-Bergshoeff MM; Schalekamp MA
    Thromb Haemost; 1984 Feb; 51(1):42-4. PubMed ID: 6426080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
    Cattaneo M; Simoni L; Gringeri A; Mannucci PM
    Br J Haematol; 1994 Feb; 86(2):333-7. PubMed ID: 8199023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DDAVP stimulates prostacyclin production.
    Belch JJ; Small M; McKenzie F; Hill PA; Lowe GD; McIntyre DE; Forbes CD; Prentice CR
    Thromb Haemost; 1982 Apr; 47(2):122-3. PubMed ID: 6808693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DDAVP in uremia.
    Vicente V; Alberca I; Macias JF; Lopez Borrasca A
    Nephron; 1984; 36(2):145-6. PubMed ID: 6420716
    [No Abstract]   [Full Text] [Related]  

  • 29. Norepinephrine and DDAVP induced rise in tissue plasminogen activator.
    Grant PJ; Wiles PG; Davies JA; Prentice CR
    Thromb Haemost; 1988 Oct; 60(2):342. PubMed ID: 3146147
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of DDAVP on plasma levels of factor VII and XII.
    Brommer EJ; Kluft C; Bertina RM; Alderkamp GH
    Br J Haematol; 1984 May; 57(1):173-5. PubMed ID: 6426497
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of propranolol, barbiturate anesthesia and splenectomy on factor VIII:C and plasminogen activator release induced by DDAVP. An experimental study on the dog.
    Pina-Cabral JM; Cunha-Monteiro A; Sousa-Dias MC; Andrade JA
    Thromb Haemost; 1989 Sep; 62(2):784-7. PubMed ID: 2510352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to fibrinolytic activity and factor VIII-related antigen to stimulation with desmopressin in hyperlipoproteinemia.
    Brommer EJ; Gevers Leuven JA; Barrett-Bergshoeff MM; Schouten JA
    J Lab Clin Med; 1982 Jul; 100(1):105-14. PubMed ID: 6806418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
    Moffat EH; Giddings JC; Bloom AL
    Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia A and von Willebrand's disease].
    Takase T; Nishino M; Yasui M; Shima M; Yoshikawa N; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1571-8. PubMed ID: 3937410
    [No Abstract]   [Full Text] [Related]  

  • 35. Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
    Brenner B; Seligsohn U; Hochberg Z
    J Clin Endocrinol Metab; 1988 Jul; 67(1):191-3. PubMed ID: 3132483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on blood coagulation in patients with hemophilia A and in healthy men].
    Blättler W; Jacky E; Müller M; Graf M
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1367-8. PubMed ID: 314661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-D-vasopressin.
    Rudd MA; Johnstone MT; Rabbani LE; George D; Ware JA; Loscalzo J
    Circulation; 1991 Dec; 84(6):2568-73. PubMed ID: 1835680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DDAVP and its effect on factor VIII activity (author's transl)].
    Sikorová J; Vorlová Z
    Cas Lek Cesk; 1981 May; 120(18):553-6. PubMed ID: 6794913
    [No Abstract]   [Full Text] [Related]  

  • 39. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL; Doyle JJ; Israels ED; Winter JS; Cheang MS; Walker RD; Bishop AJ
    Lancet; 1985 Jun; 1(8441):1293-4. PubMed ID: 2860491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DDAVP: does the drug have a direct effect on the vessel wall?
    Barnhart MI; Chen S; Lusher JM
    Thromb Res; 1983 Jul; 31(2):239-53. PubMed ID: 6415852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.